Post by marriott on Jan 29, 2023 15:52:58 GMT
Earlier this month , Rolls Royce Holdings PLC hired new CEO Tufan Erginbilgic . To be clear , Rolls Royce Holdings PLC is not Rolls-Royce Motor Cars Ltd. which a separate legal entity and owned by the BMW Group . Rolls Royce Holdings PLC is primarily an aircraft engine maker and generates 40 per cent of its revenues from its civil aerospace business .
As reported by the Financial Times , just a few days ago Mr. Erginbilgic told staff the company is a "burning platform" whose performance was "unsustainable" and faces a "last chance" to change . Further , he said "we underperform every key competitor out there," and "Rolls-Royce has not been performing for a long, long time; it has nothing to do with COVID, let's be very clear."
CEO Erginbilgic is expected to announce a sweeping and painful restructuring plan for the company.
Tough talk from the CEO who just assumed responsibilities a few weeks ago !
Now turning to Novavax ......
In an earlier message , I highlighted some thoughts about what newly appointed President and Chief Executive Officer John C. Jacobs may do to inspire confidence and trust in the company moving forward .
With the GAVI challenges, state of current and projected future vaccine demand and with no commercial products in 2023 , perhaps Mr Jacobs needs to communicate with blunt candor and confidence a vision to change Novavax's market sentiment from a " fettered platform " to a real world " commercial platform " with progressing market results !
It won't be easy but I believe it can be done !
Full disclosure : I currently own shares of Rolls Royce Holdings PLC and , of course, Novavax !
As reported by the Financial Times , just a few days ago Mr. Erginbilgic told staff the company is a "burning platform" whose performance was "unsustainable" and faces a "last chance" to change . Further , he said "we underperform every key competitor out there," and "Rolls-Royce has not been performing for a long, long time; it has nothing to do with COVID, let's be very clear."
CEO Erginbilgic is expected to announce a sweeping and painful restructuring plan for the company.
Tough talk from the CEO who just assumed responsibilities a few weeks ago !
Now turning to Novavax ......
In an earlier message , I highlighted some thoughts about what newly appointed President and Chief Executive Officer John C. Jacobs may do to inspire confidence and trust in the company moving forward .
With the GAVI challenges, state of current and projected future vaccine demand and with no commercial products in 2023 , perhaps Mr Jacobs needs to communicate with blunt candor and confidence a vision to change Novavax's market sentiment from a " fettered platform " to a real world " commercial platform " with progressing market results !
It won't be easy but I believe it can be done !
Full disclosure : I currently own shares of Rolls Royce Holdings PLC and , of course, Novavax !